IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in IDEAYA Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- +19 vs. Q3 2021
- Shares held
- 34.7M
- +1.86M (+5.7%) vs. Q3 2021
- Total value
- $820.7M
- −$17.2M (−2.1%) vs. Q3 2021
- New holders
- 27
- 48 more added
- Sold out
- 8
- 23 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,514,123 | $35.8M | 0.00% | +98,175+6.9% | Added |
| Logos Global Management LP | 1,550,000 | $36.6M | 3.78% | −225,000−12.7% | Reduced |
| State Street Corp | 1,692,707 | $40.0M | 0.00% | +653,006+62.8% | Added |
| Boxer Capital, LLC | 2,202,812 | $52.1M | 2.07% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,290,282 | $54.1M | 0.10% | −14,894−0.6% | Reduced |
| RTW Investments, LP | 2,520,076 | $59.6M | 0.87% | −746,179−22.8% | Reduced |
| Avidity Partners Management LP | 2,553,000 | $60.4M | 1.28% | +116,000+4.8% | Added |
| Canaan Partners X LLC | 2,660,713 | $62.9M | 24.52% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,701,525 | $63.9M | 0.01% | +365,619+15.7% | Added |
| BlackRock Inc. | 2,729,719 | $64.5M | 0.00% | −281,947−9.4% | Reduced |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −90,199−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −56,310−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −29,600−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −14,016−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −2,196−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −880−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −518−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |